Roidipedia.Compound reference & reporting
05 AUG 2026
CompoundsResearch chemical LSM-775
Research chemicalResearch chemicalPsychedelicLysergamide

LSM-775

Also known as Lysergic acid morpholide · LSM-775

LSM-775 is a lysergamide in which the diethylamide of LSD is replaced by a morpholide group. It is a lesser-known psychedelic reported to be shorter-acting and somewhat less potent than LSD, with a more sedated character. Human information is very limited and largely historical or anecdotal.

01 Overview

LSM-775 is the morpholide analogue of lysergic acid, differing from LSD by replacement of the diethylamide with a morpholine ring. It was investigated decades ago in early lysergamide structure-activity work and is now a rare research chemical distributed on blotter.

Reported effects are broadly psychedelic but described as shorter, milder and more sedating than LSD, with some reports emphasising a heavier or hazier quality. It has never been characterised in modern clinical studies; its profile rests on scattered historical reports and contemporary user accounts. Toxicity appears low at typical doses, with the usual psychedelic caveats around difficult experiences.

02 Mechanism

Agonist at serotonin 5-HT2A receptors, the shared mechanism of classical lysergamide psychedelics.

03 Dosing

TierDoseRouteNotes
Light100–300 mcgSublingualReported less potent than LSD; blotter potency uncertain.
Common300–700 mcgSublingualDoses are approximate given scant data.

04 Effects

EffectMagnitudeEvidence
Visual alterationVisual distortions and enhancement, reported as gentler than LSD.Milder than LSDAnecdotal
SedationA more sedated, hazy character than LSD.Anecdotal
Mood changeAltered mood, variously euphoric or muted.Anecdotal

05 Side effects

EffectSeverityFrequencyEvidenceCountermeasures
Anxiety and difficult experiencesAnxiety or challenging psychological experiences, especially at higher doses.ModerateSet-dependentAnecdotal
Cardiovascular stimulationIncreased heart rate and blood pressure.MildCommonAnecdotal
Persistent perceptual changes (HPPD)Rarely, lingering visual disturbances after use.ModerateRareAnecdotal

07 References

Structure-activity of lysergic acid amidesHistorical lysergamide pharmacology literature

08 Discussion0 comments

?
Sign in to add a comment…
Create account
Discussion is moderated. No sourcing, vendor names or price talk — those comments are removed, and repeat posts are banned.
This page is reference information, not medical advice. Doses and protocols are documented as they appear in the clinical literature and in practice — describing them is not a recommendation to use them. Countermeasures listed here are not a substitute for a physician. Legal status varies by jurisdiction and changes.